Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.
about
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting Rho GTPase effector ...... adenocarcinoma proliferation.
@en
Targeting Rho GTPase effector p21 activated kinase 4
@nl
type
label
Targeting Rho GTPase effector ...... adenocarcinoma proliferation.
@en
Targeting Rho GTPase effector p21 activated kinase 4
@nl
prefLabel
Targeting Rho GTPase effector ...... adenocarcinoma proliferation.
@en
Targeting Rho GTPase effector p21 activated kinase 4
@nl
P2093
P2860
P1476
Targeting Rho GTPase effector ...... l adenocarcinoma proliferation
@en
P2093
Amro Aboukameel
Erkan Baloglu
Irfana Muqbil
Philip A Philip
Ramzi M Mohammad
William Senapedis
Yosef Landesman
P2860
P304
P356
10.1080/21541248.2017.1329694
P577
2017-06-23T00:00:00Z